Aimmune Therapeutics

AIMT

17.15

-1.11

-6.1%

After Hours:

17.15

0.00

0.0%

Stock Price
Open: 18.20
Prev. Close: 18.26
Low/Hi: 17.12 - 19.17
52-Week: 9.77 - 27.31
Volumes
Equity: 288,701
90-Day Avg: 328,089
Option: 4
90-Day Avg: 25
Volatility
Today: 95.3
20-Day: 46.8
52-Week: 54.0
30-Day IV: 51.7 +4.4
IV Rank: 0.67 (Moderate)
Fundamental
Div. Yield: 0.0%
Earnings: 10-Aug (Est.)
P/E Ratio:
Market Cap: 919.3 M
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

AIMT Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Mar-2017 31-Dec-2016 30-Sep-2016 30-Jun-2016
Cash and Cash Equivalents 78,714 124,010 76,911 74,430
Short Term Investments 167,533 124,921 73,332 94,538
Investments - - - -
Accounts Receivable 0 0 0 0
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 2,625 2,749 2,338 3,782
Net Property Plant and Equipment 11,147 10,391 9,034 7,032
Other Current Assets 0 0 0 0
Current Assets 248,872 251,680 152,581 172,750
Goodwill and Intangibles 0 0 0 0
Long Term Investments 13,065 33,602 9,012 2,804
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 276,289 298,789 173,727 185,696
Short Term Debt 0 0 0 0
Other Non-Current Assets 3,205 3,116 3,100 3,110
Accounts Payable 1,676 1,427 1,470 1,261
Accrued Liabilities and Other Payables 8,440 9,921 10,249 4,433
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 11,571 12,817 13,228 7,167
Other Current Liabilities 107 102 128 150
Accumulated Other Comprehensive Income -122 -27 14 31
Preferred Stock 0 0 0 0
Current Liabilities 10,223 11,450 11,847 5,844
Common Stock 5 5 4 4
Other Non-Current Liabilities 1,348 1,367 1,381 1,323
Additional Paid-In Capital 424,862 420,151 269,562 265,489
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -160,027 -134,157 -109,081 -86,995
Total Equity 264,718 285,972 160,499 178,529
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Cash and Cash Equivalents 124,010 76,677 2,269
Short Term Investments 124,921 115,158 0
Investments - - -
Accounts Receivable 0 0 0
Inventory 0 0 0
Loans - - -
Prepaid Expenses 2,749 5,622 106
Net Property Plant and Equipment 10,391 2,702 87
Other Current Assets 0 0 0
Current Assets 251,680 197,457 2,375
Goodwill and Intangibles 0 0 0
Long Term Investments 33,602 7,992 0
Other Assets - - -
Long Term Receivables 0 0 0
Total Assets 298,789 212,361 2,531
Short Term Debt 0 0 0
Other Non-Current Assets 3,116 4,210 69
Accounts Payable 1,427 1,863 478
Accrued Liabilities and Other Payables 9,921 3,118 1,259
Long Term Debt 0 0 0
Other Liabilities - - -
Current Portion of Long Term Debt 0 0 0
Total Liabilities 12,817 6,110 1,860
Other Current Liabilities 102 117 67
Accumulated Other Comprehensive Income -27 -88 0
Preferred Stock 0 0 16,928
Current Liabilities 11,450 5,098 1,804
Common Stock 5 4 0
Other Non-Current Liabilities 1,367 1,012 56
Additional Paid-In Capital 420,151 259,668 1,260
Treasury Stock 0 0 0
Other Equity 0 0 0
Retained Earnings -134,157 -53,333 -17,517
Total Equity 285,972 206,251 671